Tibco Launches Spotfire Clinical To Accelerate Drug Development

Tibco is going to demonstrate a beta version of the product at the 46th Drug Information Association (DIA) Annual Meeting in Washington.

Tibco Software said that the Spotfire Clinical will enable actionable decisions that enhance patient safety, streamline operations and accelerate time to market for new medications and devices – leading to better medical outcomes for patients and allowing life sciences organizations to achieve drastically shorter development cycles and faster approvals of new medications.

By leveraging the new integrated S+/R statistics and predictive analytics capabilities of the Spotfire Analytics Platform, users will be able to conduct advanced what-if scenarios and sophisticated analysis to gain key insights into data, without the intervention of IT resources or biostatisticians.

Tibco Software claimed that Spotfire Clinical will integrate out-of-the box with systems, including Oracle Clinical and Oracle Remote Data Capture.

With these integrations, clinical development teams can leverage interactive visualizations and S+/R-based predictive analytics to rapidly explore their clinical data stored in the leading clinical data management and electronic data capture systems.

Pharmaceutical, biotechnology, medical device and contract research organizations using Spotfire Clinical will be able to visually interact with and identify patterns and trends in their data, enabling decisions that will shorten the time between critical development gates and meet operational milestones more quickly.

Ben McGraw, director of life science industry solutions for Spotfire at Tibco, said: “Prior to TIBCO Spotfire Clinical, there hasn’t been an easy way for clinical teams to interact with, visualize and analyze data from multiple systems to support faster decision-making and predict more accurate outcomes. Providing advanced, predictive analytics is one of the powerful benefits of Spotfire in the clinical environment.”